LJPCUnknown
LA JOLLA PHARMACEUTICAL CO Insider Trading Activity
Every SEC Form 4 insider transaction reported for LA JOLLA PHARMACEUTICAL CO (LJPC), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are LJPC insiders buying or selling?
LA JOLLA PHARMACEUTICAL CO insiders reported 20 open-market buys ($34.5M) and 2 sells ($13.5M) across 22 Form 4 filings — a net buying position of $21.0M.
Source: SEC EDGAR Form 4
Key Statistics (as of Dec 7, 2021)
Total Form 4 filings
22
SEC EDGAR
Insider filers
8
Insider buys (20)
$34.5M
Insider sells (2)
$13.5M
Insider sentiment
Net buyingNet insider flow of $21.0M in net buying.
Recent LJPC insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 7, 2021 | David A Ramsay | Director | Purchase | 24.5K | $3.75 | $92.0K |
| Dec 2, 2021 | Kevin C Tang | Director, 10% Owner | Sale | 441.3K | $3.93 | $1.7M |
| Nov 19, 2021 | David A Ramsay | Director | Purchase | 7.5K | $4.23 | $31.7K |
| Jun 1, 2021 | Kevin C Tang | Director, 10% Owner | Purchase | 245.0K | $4.47 | $1.1M |
| May 26, 2021 | David A Ramsay | Director | Purchase | 20.0K | $3.49 | $69.8K |
| May 26, 2021 | Kevin C Tang | Director, 10% Owner | Purchase | 398.7K | $3.96 | $1.6M |
| Sep 10, 2020 | David A Ramsay | Director | Purchase | 1.0K | $3.83 | $3.8K |
| Sep 9, 2020 | TANG KEVIN C | Director, 10% Owner | Purchase | 278.4K | $3.94 | $1.1M |
| Aug 24, 2020 | David A Ramsay | Director | Purchase | 47.0K | $3.99 | $187.5K |
| Aug 14, 2020 | TANG KEVIN C | Director, 10% Owner | Purchase | 431.6K | $3.72 | $1.6M |
| Jun 4, 2020 | TANG KEVIN C | Director, 10% Owner | Purchase | 615.1K | $4.91 | $3.0M |
| Feb 3, 2020 | TANG KEVIN C | Director, 10% Owner | Purchase | 169.8K | $6.76 | $1.1M |
| Jan 16, 2020 | Darryl Wellinghoff | Chief Commercial Officer | Purchase | 3.0K | $8.23 | $24.7K |
| Jan 13, 2020 | TANG KEVIN C | Director, 10% Owner | Purchase | 3.0M | $5.87 | $17.4M |
| Jan 31, 2019 | Lakhmir S Chawla | Chief Medical Officer | Purchase | 3.0K | $5.56 | $16.7K |
| Jan 10, 2019 | TANG KEVIN C | Director, 10% Owner | Purchase | 1.3M | $5.37 | $7.0M |
| Jan 10, 2019 | TIDMARSH GEORGE F | President, CEO & Secretary | Purchase | 2.0K | $5.85 | $11.7K |
| Jan 10, 2019 | Jennifer Carver | Chief Operating Officer | Purchase | 5.0K | $6.17 | $30.8K |
| Jan 10, 2019 | James Rolke | Chief Scientific Officer | Purchase | 1.6K | $6.09 | $9.7K |
| Jan 10, 2019 | Joseph Edelman | 10% Owner | Sale | 2.1M | $5.69 | $11.7M |
| Aug 21, 2018 | James Rolke | Chief Scientific Officer | Purchase | 1.0K | $22.00 | $22.0K |
| Aug 21, 2018 | Jennifer Carver | Chief Operating Officer | Purchase | 1.0K | $20.90 | $20.9K |
Showing the 22 most recent of 22 Form 4 filings for LA JOLLA PHARMACEUTICAL CO.
Most active LJPC insiders
- TANG KEVIN C9 filings
- David A Ramsay5 filings
- James Rolke2 filings
- Jennifer Carver2 filings
- Darryl Wellinghoff1 filing
Ask anything about LJPC insider activity
Use Trabud's AI agent to query LA JOLLA PHARMACEUTICAL CO's Form 4 history in plain English — "Show me LJPC CEO purchases this year" or compare it against any other ticker.
Open the AI agentLJPC insider trading FAQ
Are LA JOLLA PHARMACEUTICAL CO insiders buying or selling?
Across 22 SEC Form 4 filings, LA JOLLA PHARMACEUTICAL CO (LJPC) insiders reported 20 open-market purchases totaling $34.5M and 2 sales totaling $13.5M. That is a net buying position of $21.0M.
How many insiders trade LJPC stock?
8 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for LA JOLLA PHARMACEUTICAL CO. The most recent filing was accepted on Dec 7, 2021.
Where does Trabud get LJPC insider trading data?
All LJPC insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.